ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 34.2% | 37.9% | 35.9% | 35.5% | 34.7% | ||
| Changes by years, y/y, % | +4pp | -2pp | 0pp | +1.2% | ||||
ОЗОН Фармацевтика. EBITDA margin, %
ОЗОН Фармацевтика. EBITDA margin, changes, pp
ОЗОН Фармацевтика (OZPH) EBITDA margin MSFO (quarter values) |
||||||||
| 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | LTM ? | |||
| EBITDA margin, % | ? | 31.1% | 30.9% | 36.4% | 31.7% | 39.0% | 34.7% | |
| Changes by years, y/y, % | -17pp | -7pp | +3pp | -13pp | +8pp | |||
| Changes by quarters, q/q, % | -13pp | 0pp | +5pp | -5pp | +7pp | |||